RxDoctor Payments Data

Sandra Buchanan, MD

Family Medicine · Port Orange, FLNPI 1003923731

Payments from drug & device makers

$3,550in general payments, 2019–2025

Across 209 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$698
  • Novartis$360
  • Pfizer$338
  • Amgen$295
  • GSK$226
  • Novo Nordisk$202
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,50599%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,550 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$283,181
Medicare patients
418
Services billed
5,594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban197$225,982
FarxigaDapagliflozin Propanediol67$73,999
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$65,174
JardianceEmpagliflozin28$30,251
Stiolto RespimatTiotropium Br/Olodaterol Hcl21$23,658
XareltoRivaroxaban29$21,778
ProliaDenosumab11$19,595
OzempicSemaglutide20$17,474
Tresiba Flextouch U-100Insulin Degludec24$16,531
InvokanaCanagliflozin14$13,094
EntrestoSacubitril/Valsartan12$9,250
Repatha SureclickEvolocumab16$8,635
Breo ElliptaFluticasone/Vilanterol21$8,408
MyrbetriqMirabegron11$8,266
SynthroidLevothyroxine Sodium99$7,318

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$338$227,411232 claims
AstraZenecaFarxiga$158$73,99967 claims
GSKTrelegy Ellipta, Breo Ellipta$226$73,58272 claims
Boehringer IngelheimJardiance, Stiolto Respimat$97$53,90949 claims
Johnson & JohnsonXarelto, Invokana$53$34,87243 claims
AmgenProlia$295$19,59511 claims
Novo NordiskOzempic$202$17,47420 claims
NovartisEntresto, Diovan$360$13,46924 claims
Astellas Pharma US IncMyrbetriq$46$8,26611 claims
AbbVieSynthroid$698$7,31899 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Port Orange

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →